Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal
Open Access
- 16 June 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (13) , 5749-5758
Abstract
Several strategies against Alzheimer disease (AD) are directed to target Aβ-peptides. The ability of transthyretin (TTR) to bind Aβ-peptides and the positive effect exerted by some TTR stabilizers for modulating the TTR–Aβ interaction have been previously studied. Herein, key structural features of the interaction between TTR and the Aβ(12–28) peptide (3), the essential recognition element of Aβ, have been unravelled by STD-NMR spectroscopy methods in solution. Molecular aspects related to the role of the TTR stabilizer iododiflunisal (IDIF, 5) on the TTR–Aβ complex have been also examined. The NMR results, assisted by molecular modeling protocols, have provided a structural model for the TTR–Aβ interaction, as well as for the ternary complex formed in the presence of IDIF. This basic structural information could be relevant for providing light on the mechanisms involved in the ameliorating effects of AD symptoms observed in AD/TTR± animal models after IDIF treatment and eventually for designing new molecules toward AD therapeutic drugs.Keywords
Funding Information
- Consejo Superior de Investigaciones Científicas (CTQ2015-64597-C2-1-P)
- European Regional Development Fund (Norte-01-0145-FEDER-000008)
- Fundació la Marató de TV3 (20140330-31-32-33-34)
This publication has 63 references indexed in Scilit:
- Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's DiseasePLOS ONE, 2012
- Neuronal Production of Transthyretin in Human and Murine Alzheimer's Disease: Is It Protective?The Journal of Neuroscience, 2011
- Characterization of the Interaction of β-Amyloid with Transthyretin Monomers and TetramersBiochemistry, 2010
- Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidosesCurrent Opinion in Structural Biology, 2010
- Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis InhibitorsPLOS ONE, 2009
- Peptide and Protein Mimetics Inhibiting Amyloid β-Peptide AggregationAccounts of Chemical Research, 2008
- Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicityProceedings of the National Academy of Sciences, 2008
- Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug designBiochemical Journal, 2007
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteinsNature Biotechnology, 2004